Number of the records: 1
Sitagliptín a vildagliptín - inhibítory dipeptidyl-peptidázy-4
Title Sitagliptín a vildagliptín - inhibítory dipeptidyl-peptidázy-4 Author info zo zahraničnej odbornej tlače vybral Štefan Kišoň Author Kišoň Štefan 1931-2024
Note P. Aschner et al. Diabetes Care, vol. 29 (2006):pp 2632-2637.. - B. Charbonnel et al. Diabetes Care, vol. 29 (2006):pp 2638-2643.. - Dejager S. et al. Horm Metab Res., vol. 39, no. 3 (2007), pp 218-223 Sign. CD 59 Source Lekárnik : odborno-informačný mesačník. - ISSN 1335-924X. - Bojnice : Unipharma Prievidza , 2008 . - Roč. 13, č. 1 (2008), s. 51 systematics 616.379-008.64-085 * 615.252.349.7 MeSH Subject diabetes mellitus, typ 2 : farmakoterapia
dipeptidylpeptidázy a tripeptidylpeptidázy : antagonisty a inhibítory
skúšanie randomizované kontrolované ako téma
Form, Genre abstrakty
Subj. Headings inhibítory dipeptidyl-peptidázy-4 * sitagliptín * vildagliptín Additional Variant Titles Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone Vildagliptin in drug-naive patients with type 2 diabetes: A 24-week, double-blind, randomized, placebo-controlled, multiple-dose study Language Slovak Country Slovak Republic Document kind Rozpis článkov z periodík Database ARTICLES 
article
Number of the records: 1